Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Trial of Tocilizumab in Giant-Cell ArteritisThe New England journal of medicine, 2017-07, Vol.377 (4), p.317-328 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1613849 ;PMID: 28745999Full text available |
|
2 |
Material Type: Article
|
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19New England Journal of Medicine, 2020-12, Vol.383 (24), p.2333-2344 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2028836 ;PMID: 33085857Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
Treatment failure in giant cell arteritisAnnals of the rheumatic diseases, 2021-11, Vol.80 (11), p.1467-1474 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2021-220347 ;PMID: 34049857Full text available |
|
4 |
Material Type: Article
|
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trialAnnals of the rheumatic diseases, 2022-05, Vol.81 (5), p.653-661 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. 2022 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2021-221865 ;PMID: 35264321Full text available |
|
5 |
Material Type: Article
|
New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extensionRheumatology (Oxford, England), 2022-07, Vol.61 (7), p.2915-2922 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. 2021 ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/keab780 ;PMID: 34718434Full text available |
|
6 |
Material Type: Article
|
Case 18-2023: A 19-Year-Old Woman with Dyspnea and TachypneaThe New England journal of medicine, 2023-06, Vol.388 (24), p.2275-2286 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMcpc2300894 ;PMID: 37314709Full text available |
|
7 |
Material Type: Article
|
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestationsArthritis research & therapy, 2021-01, Vol.23 (1), p.8-8, Article 8 [Peer Reviewed Journal]COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-020-02377-8 ;PMID: 33407817Full text available |
|
8 |
Material Type: Article
|
A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritisArthritis research & therapy, 2023-10, Vol.25 (1), p.1-199, Article 199 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-023-03177-6 ;PMID: 37840134Full text available |
|
9 |
Material Type: Article
|
Case 3-2021: A 48-Year-Old Man with Transient Vision LossThe New England journal of medicine, 2021-01, Vol.384 (4), p.363-372 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMcpc2002416 ;PMID: 33503346Full text available |
|
10 |
Material Type: Article
|
A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell ArteritisRheumatology and therapy., 2020-12, Vol.7 (4), p.793-810 [Peer Reviewed Journal]The Author(s) 2020 ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2198-6576 ;EISSN: 2198-6584 ;DOI: 10.1007/s40744-020-00227-2 ;PMID: 32844378Full text available |
|
11 |
Material Type: Article
|
Pearls & Oy-sters: Neuro-Sweet disease presenting as ischemic stroke and aseptic meningitisNeurology, 2018-12, Vol.91 (23), p.e2197-e2199 [Peer Reviewed Journal]2018 American Academy of Neurology ;2018 American Academy of Neurology 2018 American Academy of Neurology ;ISSN: 0028-3878 ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000006628 ;PMID: 30510029Full text available |
|
12 |
Material Type: Article
|
Design of the Tocilizumab in Giant Cell Arteritis TrialInternational Journal of Rheumatology, 2013-01, Vol.2013, p.912562-10 [Peer Reviewed Journal]Copyright © 2013 Sebastian H. Unizony et al. ;COPYRIGHT 2013 Hindawi Limited ;Copyright © 2013 Sebastian H. Unizony et al. 2013 ;ISSN: 1687-9260 ;EISSN: 1687-9279 ;DOI: 10.1155/2013/912562 ;PMID: 23653652Full text available |
|
13 |
Material Type: Article
|
Acute fibrinous and organizing pneumonia in systemic lupus erythematosus: A case report and review of the literaturePathology international, 2010-11, Vol.60 (11), p.755-759 [Peer Reviewed Journal]2010 The Authors. Pathology International © 2010 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd ;2010 The Authors. Pathology International © 2010 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd. ;ISSN: 1320-5463 ;EISSN: 1440-1827 ;DOI: 10.1111/j.1440-1827.2010.02586.x ;PMID: 20946526Full text available |
|
14 |
Material Type: Article
|
Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritisRheumatic & musculoskeletal diseases open, 2023-04, Vol.9 (2), p.e002923 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 ;ISSN: 2056-5933 ;EISSN: 2056-5933 ;DOI: 10.1136/rmdopen-2022-002923 ;PMID: 37024237Full text available |
|
15 |
Material Type: Article
|
Risk of Potential Glucocorticoid-Related Adverse Events in Patients with Giant Cell Arteritis: Results from a USA-Based Electronic Health Records DatabaseRheumatology and therapy., 2019-12, Vol.6 (4), p.599-610 [Peer Reviewed Journal]The Author(s) 2019 ;The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2198-6576 ;EISSN: 2198-6584 ;DOI: 10.1007/s40744-019-00180-9 ;PMID: 31656021Full text available |
|
16 |
Material Type: Article
|
The Effects of Treatment on Body Mass Index in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA TrialRheumatology and therapy., 2022-04, Vol.9 (2), p.497-508 [Peer Reviewed Journal]The Author(s) 2021 ;2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2198-6576 ;EISSN: 2198-6584 ;DOI: 10.1007/s40744-021-00411-y ;PMID: 34954809Full text available |
|
17 |
Material Type: Article
|
Case 7-2015: A 25-Year-Old Man with Oral Ulcers, Rash, and OdynophagiaThe New England journal of medicine, 2015-02, Vol.372 (9), p.864-872 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMcpc1413303Full text available |
|
18 |
Material Type: Article
|
Ocular inflammatory disease in patients with polymyalgia rheumatica: A case series and review of the literatureClinical Rheumatology, 2016-01, Vol.35 (1), p.251-258 [Peer Reviewed Journal]Clinical Rheumatology 2014 ;International League of Associations for Rheumatology (ILAR) 2015 ;ISSN: 0770-3198 ;EISSN: 1434-9949 ;DOI: 10.1007/s10067-014-2558-6 ;PMID: 24696366Full text available |
|
19 |
Material Type: Article
|
Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patientsRheumatic & musculoskeletal diseases open, 2017, Vol.3 (2), p.e000570-e000570 [Peer Reviewed Journal]Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2017 ;ISSN: 2056-5933 ;EISSN: 2056-5933 ;DOI: 10.1136/rmdopen-2017-000570 ;PMID: 29299342Full text available |
|
20 |
Material Type: Article
|
An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapyAnnals of the rheumatic diseases, 2017-05, Vol.76 (5), p.898-905 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2016-210070 ;PMID: 27927642 ;CODEN: ARDIAOFull text available |